# Optimal Dosing of Omeprazole in Neonates

> **NCT01657578** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 55 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease (GERD)

## Interventions

- **DRUG:** Omeprazole

## Key facts

- **NCT ID:** NCT01657578
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2010-12
- **Final completion:** 2012-02
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2012-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01657578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01657578, "Optimal Dosing of Omeprazole in Neonates". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01657578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*